Asthma + Lung UK advocates for lung patients facing rising living costs
Like many places in the world right now, living costs are rising sharply in the UK. This is particularly concerning for people with lung conditions who...
Asthma + Lung UK raises funds for lifesaving research
Asthma + Lung UK is coordinating ‘Team Breathe’ for the Royal Parks Half Marathon in London to raise money for lifesaving research into lung disease.
The...
Asthma-Allergy Denmark establishes research foundation
Asthma-Allergy Denmark recently opened its own research foundation to award scholarships and financial assistance for research and other scientific initiatives...
Longfonds urges Dutch municipalities to take action on air pollution
In the Netherlands, almost 1 million people with lung disease suffer due to air pollution. 50,000 people ended up in hospital at least once in the past...
NAAF launches new app for peer support in Norway
The Norwegian Asthma and Allergy Association (NAAF) launched an application to provide the opportunity to meet peers or relatives of those living with...
NAAF prepares for pollen season in Norway
In February, the Norwegian Asthma and Allergy Association (NAAF) issued its first pollen warning of the 2022 season through its daily national pollen alert...
EFA Annual General Meeting 2022
EFA's Annual General Meeting 2022
On 31st March 2022, EFA held its Annual General Meeting (AGM) in an online format. The AGM was followed by two membership...
CURE Asthma concludes with a final conference
March saw the conclusion of CURE, a four-year long research project funded by the European Union Programme Horizon 2020 which explored new approaches to...
Food allergy patients express concerns over substitutes to sunflower oil and labelling
Apart from terrible costs in human lives and suffering, the Russian war against Ukraine has considerable implications for food availability across Europe...
EFA 2022 Project: GUIDE Asthma
In 2022, EFA will work alongside the Global Initiative for Asthma (GINA) to further develop patient guidelines for asthma patients and their carers...
Review of the Energy Performance of Buildings Directive (EPBD): another missed opportunity to address indoor air pollution in Europe?
In December 2021, the European Commission’s Directorate General for Energy published its proposal for an updated Energy Performance of Buildings Directive...
EFA response to EU Food Information to Consumers Regulation raises concerns that gaps on food allergen information are forgotten
In December 2020, the European Commission launched the revision of the Food Information to Consumers (FIC) regulation 1169/2011, the main EU legislation...
The new Health Emergency and Response Authority unveils its first workplan
Established at the end of 2021, the Health Emergency Preparedness and Response Authority (HERA) has set up to improve EU coordinated response on the prevention,...
EU Air Quality Directives targeted survey: EFA unveils the many improvements the EU can take to protect patients from air pollution
In 2020, the European Commission launched a consultative process to review the current EU Air Quality Directives. As an organisation representing allergy,...
EFA Annual General Meeting 2022 (online)
For a third year in a row, EFA Annual General Meeting Business Session will be conducted online, after careful consultation with Members. The uncertainty...
Save the Date: CURE Asthma Project Final Conference
EFA invites you to the CURE conference: “Towards a CURE for Asthma: Accelerating Innovation in Personalised Medicine and Phage Therapies,” which takes...
Do not miss a date! EFA's International 2022 Calendar
Look forward to all the upcoming dates and activities to advocate for patients with allergy, asthma and COPD! To follow the international campaign days...
EFA participates in European Commission targeted workshop on the EU General Pharmaceuticals Legislation
In January 2022, EFA participated in a targeted workshop on the EU General Pharmaceuticals Legislation that the European Commission has opened for revision....
EFA response to European Commission consultation on the EU General Pharmaceuticals Legislation
EFA has responded to the much-awaited European Commission revision of the EU general pharmaceuticals legislation in December 2021 to ensure allergy and...
European Parliament Interest Group event on ‘Addressing unmet patient needs in allergy and asthma care’
The European Parliament Interest Group on Allergy & Asthma and EFA organised a virtual policy event on ‘Addressing unmet patient needs in allergy...